These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Indinavir: lightening the load. MacDougall DS. J Int Assoc Physicians AIDS Care; 1996 Aug; 2(8):6-11. PubMed ID: 11363759 [Abstract] [Full Text] [Related]
28. Predictive factors for response to a boosted dual HIV-protease inhibitor therapy with saquinavir and lopinavir in extensively pre-treated patients. von Hentig N, Babacan E, Staszewski S, Stürmer M, Doerr HW, Lötsch J. Antivir Ther; 2007 Aug; 12(8):1237-46. PubMed ID: 18240863 [Abstract] [Full Text] [Related]
29. Soft gel saquinavir has high exposure. AIDS Alert; 1997 Dec; 12(12):143-4. PubMed ID: 11364835 [Abstract] [Full Text] [Related]
33. AIDS task force grapples with faster access to protease drugs. Mascolini M. J Int Assoc Physicians AIDS Care; 1995 Mar; 1(2):6-11. PubMed ID: 11362314 [Abstract] [Full Text] [Related]
34. Lottery opens 2,000 slots for protease trial. AIDS Alert; 1995 Nov; 10(11):144. PubMed ID: 11362929 [Abstract] [Full Text] [Related]
35. [Good experiences with saquinavir. Double boosting of protease inhibitors gains significance]. MMW Fortschr Med; 2004 Apr 26; 146 Spec No 1():44. PubMed ID: 15373047 [No Abstract] [Full Text] [Related]